The impact of COVID-19 on thyroid function and psychological state of Graves’ disease: a one-year prospective study

The impact of COVID-19 on thyroid function and psychological state of Graves’ disease: a one-year prospective study

BackgroundSince the comprehensive lifting of coronavirus disease 2019 (COVID-19) pandemic control measures in mainland China in December 2022, the population has experienced widespread infection with COVID-19. COVID-19 affects multiple systems, including the endocrine system, particularly the thyroi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lujia Xu, Jianbo Zhang, Riping Cong, Yujian Zhang, Xuenan Song, Wei Wang, Yingli Diao, Haijiao Liu, Kuanxiao Tang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Endocrinology
Subjects:	COVID-19 Graves’ disease thyroid function psychological state medical intervention
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1597083/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Targeted immunotherapies for Graves’ thyroidal & orbital diseases
by: Alan Chun Hong Lee, et al.
Published: (2025-03-01)

Prevalence of Graves ophthalmopathy among patients with thyroid disease
by: Erwin D. Palisoc, MD, et al.
Published: (2010-06-01)

Graves' disease: A rare fate of Hashimoto's thyroiditis
by: Rahul Jadhav, et al.
Published: (2021-03-01)

Graves’ disease with hyperfunctioning thyroid nodule harboring thyroid carcinoma. Case report and literature review
by: A. A. Kuprin, et al.
Published: (2020-02-01)

Thyroid‐Targeted Nano‐Bombs Empower HIFU for Graves' Disease
by: Binhao Wang, et al.
Published: (2025-03-01)

99mTc-pertechnetate cut-off to distinguish Graves\' disease from subacute thyroiditis
by: Amir Gholami, et al.
Published: (2025-06-01)

Comparison of clinical and histopathological characteristics of differentiated thyroid cancers in euthyroid nodular goiter and Graves’ disease
by: İnan Güden, et al.
Published: (2025-08-01)

A randomized controlled trial on the effect of hydroxychloroquine in mild Graves’ orbitopathy (GO-HCQ): study protocol
by: Chia-Hung Lin, et al.
Published: (2025-08-01)

Update on pathogenesis and immunology of Graves’ ophthalmopathy
by: Larysa Krajewska-Węglewicz, et al.
Published: (2018-12-01)

Characteristics of patients with Graves’ disease who developed drug resistance and required surgery
by: Yusuke Shibata, et al.
Published: (2025-04-01)

Prediction of fetal Graves’ disease among pregnant women with Graves’ disease who have undergone thyroidectomy or radioactive iodine therapy: A retrospective observational study
by: Aiko Hosoda, et al.
Published: (2025-07-01)

Graves’ Disease: Is It Time for Targeted Therapy? A Narrative Review
by: Nicola Viola, et al.
Published: (2025-03-01)

The role of apoptosis in development of autoimmune thyroid diseases
by: Yu. V. Nedosekova, et al.
Published: (2009-02-01)

Graves’ disease diagnosed nearly six months after microwave ablation of benign thyroid nodules: a case report
by: Yunru Gu, et al.
Published: (2025-01-01)

Thyroid storm-induced acute liver dysfunction and portal hypertension in a patient with Graves' disease: a case report
by: Mouna Medhioub, et al.
Published: (2024-12-01)

Prevalence and aggressiveness of papillary thyroid carcinoma in surgically-treated graves’ disease patients: a retrospective matched cohort study
by: Eunice You, et al.
Published: (2019-08-01)

A Graves' Disease Patient Diagnosed as Autoimmune Gastritis with Helicobacter pylori Infection
by: Yong Hwan Ahn, et al.
Published: (2022-12-01)

Current Diagnosis and Management of Graves’ Disease
by: Imam Subekti, et al.
Published: (2018-06-01)

Current Diagnosis and Management of Graves’ Disease
by: Imam Subekti, et al.
Published: (2018-06-01)

Application of Thyroid Hormones in Women’s Hair for the Non-Invasive Prediction of Graves’ Disease
by: Kouhei Igarashi, et al.
Published: (2025-02-01)

Inactive Graves’ orbitopathy: to treat or not to treat?
by: O. G. Panteleeva, et al.
Published: (2023-03-01)

Evaluation of ultrasound accuracy in thyroid mass measurement and its impact on 131I treatment for Graves’ disease
by: Xiangxiang Li, et al.
Published: (2025-07-01)

Microvascular Ultrasonography Vascularity Index as a Rapid and Simplified Assessment Tool for Differentiating Graves’ Disease from Destructive Thyroiditis and Managing Thyrotoxicosis
by: Han-Sang Baek, et al.
Published: (2025-06-01)

Expression levels of T cell-related immune factors and their correlation with thyroid function in Graves’ disease with varied serum iodine status: insights into immunopathogenesis
by: Lilan Wang, et al.
Published: (2025-08-01)

Retinal and Choroidal Alterations in Thyroid-Associated Ophthalmopathy: A Systematic Review
by: Alexandra Magdalena Ioana, et al.
Published: (2025-02-01)

Radiological Features of Thyroid Eye Disease (TED)
by: Ayushi Agarwal, et al.
Published: (2020-10-01)

Evaluating the technetium-99 m pertechnetate flow protocol for Graves’ disease: methodological insights: a case series
by: Jaber Abdulwahab Asiri, et al.
Published: (2025-07-01)

Multi-disciplinary collaboration in diagnosing thymic hyperplasia in a Graves’ disease patient
by: Khin Yadanar Kyaw, et al.
Published: (2025-04-01)

Effectiveness of Xiakucao Oral Liquid combined with methimazole on early thyroid function recovery and treatment compliance in Graves’ disease: a real-world retrospective cohort study
by: Dong Lin, et al.
Published: (2025-06-01)

IMMUNOLOGICAL AND MORPHOLOGICAL PREDICTORS OF CLINICAL HETEROGENEITY OF PATIENTS WITH GRAVES' DISEASE (BASED ON RESEARCH OF THE THYROID GLAND OPERATIONAL MATERIAL)
by: T. V. Saprina, et al.
Published: (2015-02-01)

Management of Graves’ upper eyelid retraction (GUER): A review
by: Akruti Desai, et al.
Published: (2025-02-01)

Radioiodine Thyroid Ablation in Graves′ Hyperthyroidism: Merits and Pitfalls
by: J. Nwatsock, et al.
Published: (2012-01-01)

The role of IL-6 in thyroid eye disease: an update on emerging treatments
by: Jennifer Murdock, et al.
Published: (2025-04-01)

Transition from hypothyroidism to Graves’ disease, development of thyroid eye disease, progression to optic neuropathy after inpatient pulse therapy, and long-term administration of outpatient pulse therapy: a case report with review of literature
by: Koichiro Mizuochi, et al.
Published: (2025-01-01)

Transnasal endoscopic orbital decompression in Graves’ disease: experience of 20 years in Hospital of Egas Moniz
by: Luís André Baptista, et al.
Published: (2024-12-01)

Correction: The role of IL-6 in thyroid eye disease: an update on emerging treatments
by: Jennifer Murdock, et al.
Published: (2025-07-01)

A study of the histopathological spectrum of thyroid neoplasms in a tertiary health care center
by: Rabia Parveen Siddiqui, et al.
Published: (2024-12-01)

Thyroid peroxidase antibodies and their role in predicting outcomes in Graves’ disease treatment
by: Klara Gewert, et al.
Published: (2025-04-01)

Does hyperthyroidism worsen prognosis of thyroid carcinoma? A retrospective analysis on 2820 consecutive thyroidectomies
by: Fabio Medas, et al.
Published: (2018-01-01)

Goiter index: an easily available ultrasonographic index for thyroid volume in autoimmune thyroid diseases
by: Tsukasa Murakami, et al.
Published: (2025-08-01)